If you have been reading about growth hormone secretagogue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-03. Numbers and descriptions here follow the published literature rather than marketing material.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentapeptide | Growth hormone secretagogue family |
| Molecular mass | Approximately 711.9 Da | Free base, calculated value |
| Receptor target | GHS-R1a, the ghrelin receptor | Agonist activity reported |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C-terminal amide |
| Reported selectivity | Little change in ACTH, cortisol, prolactin | Based mainly on animal data |
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
杂质谱一般包含缺失序列片段、差向异构体、氧化产物以及残留溶剂或反离子，其中组氨酸与芳香残基的氧化常被重点关注。反相色谱中这类杂质往往紧邻主峰洗脱，因此方法需要足够的分离度并经过系统适用性验证。纯度百分比的解读依赖于检测波长与梯度条件，不同实验室公布的数字不宜直接横向比较。参考标准品有助于跨批次对照，但其自身赋值同样需要可追溯来源。
冻干状态下的肽通常比溶液状态更稳定，常规做法是维持 -20 °C 或更低温度、保持干燥并避开强光。复溶后的降解主要来自水解、氧化与脱酰胺，速率受 pH、缓冲液种类、离子强度与温度共同影响，碱性条件一般会加快这些反应。反复冻融会造成聚集与容器吸附损失，分装保存能降低该风险。容器材质与金属离子也可能参与氧化过程，需与操作条件一并考虑。
对 ipamorelin 的常规表征以反相高效液相色谱测定纯度，检测波长多设为 214 nm，因为肽键在该波长有较强吸收。身份确认通常借助电喷雾电离质谱或串联质谱，将实测分子量与理论值逐项比对。序列层面可用肽图分析或氨基酸分析进一步验证。这些手段组合起来，可以分别覆盖纯度、身份与序列三个不同层次的信息。
=== Mono(ADP-ribosyl)ation === Mono(ADP-ribosyl)transferases commonly catalyze the addition of ADP-ribose to arginine side chains using a highly conserved R-S-EXE motif of the enzyme. The reaction proceeds by breaking the bond between nicotinamide and ribose to form an oxonium ion. Next, the arginine side chain of the target protein then acts a nucleophile, attacking the electrophilic carbon adjacent to the oxonium ion. In order for this step to occur, the arginine nucleophile is deprotonated by a glutamate residue on the catalyzing enzyme. Another conserved glutamate residue forms a hydrogen bond with one of the hydroxyl groups on the ribose chain to further facilitate this nucleophilic attack. As a result of the cleavage reaction, nicotinamide is released. The modification can be reversed by (ADP-ribosyl)hydrolases, which cleave the N-glycosidic bond between arginine and ribose to release ADP-ribose and unmodified protein; NAD+ is not restored by the reverse reaction.
Ferric chloride test (detects abnormal metabolites in urine) Ninhydrin paper chromatography (detects abnormal amino acid patterns) Guthrie test (detects excessive amounts of specific amino acids in blood) The dried blood spot can be used for multianalyte testing using Tandem Mass Spectrometry (MS/MS). This given an indication for a disorder. The same has to be further confirmed by enzyme assays, IEX-Ninhydrin, GC/MS or DNA Testing. Quantitative measurement of amino acids in plasma and urine IEX-Ninhydrin post-column derivitization liquid ion chromatography (detects abnormal amino acid patterns and quantitative analysis) Urine organic acid analysis by gas chromatography–mass spectrometry Plasma acylcarnitine analysis by mass spectrometry Urine purine and pyrimidine analysis by gas chromatography-mass spectrometry Specific diagnostic tests (or focused screening for a small set of disorders):
Carbon dioxide is a chemical compound with the chemical formula CO2. It is made up of molecules that each have one carbon atom covalently double bonded to two oxygen atoms. It is found in a gas state at room temperature and at normally-encountered concentrations it is odorless. As the source of carbon in the carbon cycle, atmospheric CO2 is the primary carbon source for life on Earth. In the air, carbon dioxide is transparent to visible light but absorbs infrared radiation, acting as a greenhouse gas. Carbon dioxide is soluble in water and is found in groundwater, lakes, ice caps, and seawater. It is a trace gas in Earth's atmosphere at 428 parts per million (ppm), or about 0.043% (as of July 2025) having risen from pre-industrial levels of 280 ppm or about 0.028%. Burning fossil fuels is the main cause of these increased CO2 concentrations, which are the primary cause of climate change. Its concentration in Earth's pre-industrial atmosphere since late in the Precambrian was regulated by organisms and geological features. Plants, algae and cyanobacteria use energy from sunlight to synthesize carbohydrates from carbon dioxide and water in a process called photosynthesis, which produces oxygen as a waste product. In turn, oxygen is consumed and CO2 is released as waste by all aerobic organisms when they metabolize organic compounds to produce energy by respiration. CO2 is released from organic materials when they decay or combust, such as in forest fires.
==== CamAPS FX ==== CamAPS FX, a product of CamDiab Ltd, is a mobile app designed for individuals with type 1 diabetes. It operates in conjunction with various insulin pumps, including the mylife YpsoPump, DANA Diabecare RS, and DANA-i insulin pumps, and is compatible with continuous glucose monitoring systems such as the Dexcom G6 and Abbott FreeStyle Libre 3. The system utilizes a self-learning algorithm that adapts insulin delivery based on glucose data, adjusting every 8–12 minutes, and it is approved for use in individuals aged one year and older, with age requirements varying depending on the CGM system used. CamAPS FX is controlled via a smartphone app, currently available for Android devices, with iOS support in development. The app allows users to set personalized glucose targets and offers features like "Ease-off" and "Boost" modes to adjust insulin needs, as well as a "Slowly absorbed meal" function for managing the effects of high-fat or low-glycemic meals. Remote monitoring capabilities are included through app-based sharing and SMS alerts. The system’s algorithm, developed at the University of Cambridge, has been validated in multiple clinical trials, showing consistent improvements in glycemic control and quality of life.
Other important structures The most notable supersecondary structure is a five chain beta sheet that is composed of a β-meander and a β-α-β clockwise unit. It is present in both domains suggesting that the protein arose from gene duplication.
Sources: en.wikipedia.org
Electric tweezers Transdermal electrolysis Transcutaneous hair removal Microwave hair removal Foods and dietary supplements Non-prescription topical preparations (also called "hair inhibitors", "hair retardants", or "hair growth inhibitors")
=== Azerbaijani === In Azerbaijani, which is an agglutinative language, there is theoretically no limit on word compounding.An example is the 42-letter word Elektrikləşdirdiklərimizdənsinizmişcəsinə; pronounced [elektɾiklæʃdiɾdiklæɾimizˈdænsinizmiʃdʒæsinæ] , which translates to "As if you were from those ones we have electrified". There is a shorter more well-known 32-long word, which is a tongue twister, too — Elektrikləşdirilmişlərdənsinizmi?; pronounced [elektɾiklæʃdiɾilmiʃlæɾˈdænsinizmi] meaning "Are you from the ones who are electrified?".
Fake-fiction is a genre that deliberately presents real, unscripted events in the form of a fiction film, making them appear staged. The concept was introduced by Pierre Bismuth to describe his 2016 film Where is Rocky II?
On November 13, 2023, an Inspection by the Administration of Food Safety, Veterinary Medicine and Plant Protection of the Republic of Slovenia banned the sale of Prime energy drinks in Slovenia as they contain L-theanine, which is not allowed in non-alcoholic beverages. Prime Hydration may be freely sold.
== External links == Tetrodotoxin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Tetrodotoxin: essential data (1999) Tetrodotoxin from the Bad Bug Book at the U.S. Food and Drug Administration website New York Times, "Whatever Doesn't Kill Some Animals Can Make Them Deadly" U.S. National Library of Medicine: Hazardous Substances Databank – Tetrodotoxin
Sources: en.wikipedia.org
While the 2015 DGA report does advise for a reduced level of consumption of red and processed meats, the 2015–2020 DGA key recommendations recommend that a variety of protein foods be consumed, including both vegetarian and non-vegetarian sources of protein.
[T]he Iraqi people, who were not consulted about the invasion, have paid the price for their government's madness ... Iraqis understood the legitimacy of a military action to drive their army from Kuwait, but they have had difficulty comprehending the Allied rationale for using air power to systematically destroy or cripple Iraqi infrastructure and industry: electric power stations (92 percent of installed capacity destroyed), refineries (80 percent of production capacity), petrochemical complexes, telecommunications centers (including 135 telephone networks), bridges (more than 100), roads, highways, railroads, hundreds of locomotives and boxcars full of goods, radio and television broadcasting stations, cement plants, and factories producing aluminum, textiles, electric cables, and medical supplies. However, the UN subsequently spent billions rebuilding hospitals, schools, and water purification facilities throughout the country.
tau+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH) GeneReviews/NCBI/NIH/UW entry on MAPT-Related Disorders MR scans of variant CJD CSF tau-positive man Overview of all the structural information available in the PDB for UniProt: P10636 (Microtubule-associated protein tau) at the PDBe-KB.
More recent publications have defined the usually recommended doses as 50 mg DMT and 100 mg harmaline orally. Besides DMT with harmaline, the properties and effects of oral DMT in combination with harmine have also been studied by Jonathan Ott. He found that the threshold dose was 20 or 30 mg DMT and 120 mg harmine orally. Shulgin also reported in TiHKAL that 35 to 40 mg DMT and 140 to 190 mg harmine were unmistakably active, whereas smaller doses of 30 mg DMT and 120 to 140 mg harmine orally were inactive. In notable contrast to harmaline, harmine does not have its own psychoactive effects when used at doses of up to at least 300 mg orally. In pharmahuasca, the harmala alkaloid is usually taken first and then DMT is taken 15 to 20 minutes later, although a shorter or longer interval may also be employed. The onset of oral DMT with an MAOI is within 1 hour and its duration is 4 to 6 hours.
Sources: en.wikipedia.org
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.
Both bind the same receptor, but ghrelin is a 28-amino-acid hormone with roles in appetite and energy balance. Ipamorelin is a much smaller synthetic peptide selected for growth hormone release with limited effect on appetite signaling in animal models. The full overlap between their effects is not completely mapped.
Most published data come from animal studies and a small number of human trials. Findings on growth hormone release are reasonably consistent, while long-term effects and direct comparisons with other secretagogues remain incompletely studied. Open questions include duration of action across different populations.
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.